IBM has just kicked off a cool collaboration dance with Boehringer Ingelheim, the global research folks. What’s the buzz? They’re teaming up to tap into the power of AI foundation models for the quest of discovering fresh antibody treatments.
IBM has just kicked off a cool collaboration dance with Boehringer Ingelheim, the global research folks. What’s the buzz? They’re teaming up to tap into the power of AI foundation models for the quest of discovering fresh antibody treatments.
